Patent · US Active

Peptides useful as cell-penetrating peptides

US9403884B2 · kind B2 · utility

1Cited by

6References

10Claims

0Family size

Assignee

Evonik Röhm GmbH · DE

Inventors

Roland Brock · Kalkar, DE
Rainer Fischer · Monschau, DE
Mariola FOTIN-MLECZEK · Sindelfingen, DE
Hansjoerg Hufnagel · Reken, DE
Norbert Windhab · Hofheim, DE

Key dates

Filing date	Jul 25, 2012
Grant date	Aug 2, 2016
Priority date	—
Expiry date	Dec 10, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A peptide having an amino acid sequence containing at least eight consecutive amino acids of the human lactoferrin protein or of the bovine lactoferrin protein. The peptide is suitable as a cell-penetrating peptide. A complex of the peptide and a cargo molecule non-covalently bound to the peptide. The cargo molecule may be a nucleic acid, an amino acid, a peptide, a protein, a carbohydrate, a lipid, or a small molecule. A method of penetrating or transfecting a cell using the complex.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.